ACC最新数据分享..ppt

Limitations Patients with AMI, CTO, bifurcation, LMCA lesion, SVG lesion, ostial lesions or lesions with thrombus or excessive tortuosity or calcification were excluded Event rates were lower than expected; non-inferiority based on a delta of 3.5% was demonstrated, but small differences between PtCr-EES and CoCr-EES cannot be excluded Trial was not designed to assess differences in deliverability, acute performance or ease of use Conclusions A novel PtCr-EES has been developed which has been shown to be noninferior to the predicate CoCr-EES for TLF, with non-significant differences in measures of safety and efficacy demonstrated through 12-month follow-up after PCI ACC最新数据分享 Thanks! * * * * * * a, target-vessel failure (a composite of cardiovascular death, MI and clinically driven target-vessel revascularization) ; b, a composite of death, MI, cerebrovascular accident, stent thrombosis, and TIMI major bleeding; c, definite or probable stent thrombosis by ARC definition; d, overt clinical bleeding with a drop of hemoglobin of 5 g/dl or hematocrit of 15%; e, a composite of death, MI, stent thrombosis, cerebrovascular accident, and TIMI major bleeding. * * * * * * * * * * * SE2934380 Rev. A. SE2934380 Rev. A. SE2934380 Rev. A. SE2934323 Rev. A.. SE2934380 Rev. A. SE2934380 Rev. A. ACC最新数据分享 北京潞河医院心内科 郭金成 Premier of randomized comparison of bypass surgery versus angioplasty using sirolimus-eluting stent in patients with left-main coronary artery disease (PRECOMBAT) trial Result: PCI with SES was noninferior to CABG in terms of MACCE (all-cause death, MI, stroke, TVR) at 2 years, TVR in the PCI and CABG group, 9.0% vs 4.2% (p=0.02). MACCE rate at 12 and 24 months Primary endpoint (MACCE) PCI with SES (n=300) CABG (n=300) P value 12 months 8.7% 6.7% 0.01 24 months 12.2% 8.1% 0.12 Conclusion: a wide noninferiority margin(7%) mean that the results cannot be considered clinically directive at the present time. Purpose: To assess whe